If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth?In recent posts on Seeking Alpha, I have covered a number of companies developing drugs within a class most commonly referred to as glucagon-like peptide ("GLP") receptor agonists, or GLP-RA, or GLP-1s. These includ ...